Physician profile
David J Ternes
NPI 1487866844
$1,739.29
in general payments reported to CMS, 2019-2025
19 companies · $87.87 in 2025
The $87.87 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $726 · 2020: $97.88 · 2021: $175 · 2022: $325 · 2023: $57.69 · 2024: $270 · 2025: $87.87.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $395 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $395.22 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $370.90 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $269.09 | 2019-2024 | Xarelto |
| Astellas Pharma US INC | $179.98 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $123.48 | 2023-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $114.31 | 2019-2022 | |
| Pfizer INC. | $107.10 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $100.97 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $95.49 | 2019-2024 | Jardiance |
| Amgen INC. | $95.10 | 2022-2025 | Repatha |
| Abbott Laboratories | $57.71 | 2022-2024 | Optis |
| Sanofi-Aventis U.S. LLC | $43.34 | 2019 | |
| Heartflow, INC. | $29.79 | 2025 | |
| Arbor Pharmaceuticals, INC. | $28.95 | 2019-2020 | |
| Inari Medical, INC. | $25.38 | 2021 | |
| Philips North America LLC | $23.31 | 2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $21.82 | 2024 | Injectafer |
| Csl Behring | $20.00 | 2024 | Kcentra |
| Edwards Lifesciences Corporation | $17.84 | 2022 | |
| Ekos Corporation | $14.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Ternes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.